NEW YORK, July 23, 2019 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05797198/?utm_source=PRN
Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market: OverviewRising prevalence of mental illnessesThe rising prevalence of mental illnesses, especially in the US, has been increasing the sales of neurological drugs such as SSRIs. These drugs have proven efficacy in treating depression. SSRIs are more effective compared with other available antidepressants. The growth potential of the market will attract new entrants. Therefore, the market is expected to record a CAGR of almost 4% during the forecast period.Growing geriatric populationMental disorders are common among older adults. The primary reason being most of the geriatric population have two or more chronic health conditions such as cardiovascular disease, hypertension, diabetes, and cancer, which are high-risk factors for mental disorders. The prevalence rate of mental conditions among the geriatric population is rising. Favorable health insurance policies are allowing people of this age group to avail treatment for mental disorders. This is creating market opportunities for vendors. Therefore, the growing geriatric population will have a positive impact on the overall market growth.
Competitive LandscapeWith the presence of several major players, the global selective serotonin reuptake inhibitors market is fragmented. This robust vendor analysis is designed to help clients in improving their market position, and in line with this, this report provides a detailed analysis of several leading selective serotonin reuptake inhibitors producers, which include Allergan Plc, Eli Lilly and Co., GlaxoSmithKline Plc, H. Lundbeck AS, and Pfizer Inc.Also, the selective serotonin reuptake inhibitors market analysis report includes information on upcoming trends and challenges that will influence the market growth. This is to help companies in strategizing and leveraging on all forthcoming growth opportunities.Read the full report: https://www.reportlinker.com/p05797198/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/global-selective-serotonin-reuptake-inhibitors--ssris-market-2019-2023-300889764.html
Subscribe to our Free Newsletters!